Patents Assigned to Ventria Biosciences Inc.
  • Cell culture media containing combinations of proteins
    Patent number: 11492389
    Abstract: The present invention relates to cell culture media supplements or complete media compositions comprising plant-produced heterologous recombinant human albumin, as well as methods of making the cell culture media, and methods of using the supplemented cell culture media to improve viability, productivity, and growth characteristics of cultured cells.
    Type: Grant
    Filed: June 7, 2022
    Date of Patent: November 8, 2022
    Assignee: Ventria Biosciences Inc.
    Inventors: Steven Clyde Pettit, Mary Ann Michelle Fernandez Santos, Ning Huang
  • Cell culture media containing combinations of proteins
    Patent number: 10981974
    Abstract: The present invention relates to cell culture media supplemented with a plant-produced recombinant mammalian albumin supplement, as well as methods of making the cell culture media, and methods of using the supplemented cell culture media to improve growth characteristics of cultured cells.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: April 20, 2021
    Assignee: Ventria Bioscience Inc.
    Inventors: Steven Clyde Pettit, Mary Ann Michelle Fernandez Santos, Ning Huang
  • Cell culture media containing combinations of proteins
    Patent number: 10618951
    Abstract: The present invention relates to cell culture media containing combinations of proteins, as well as methods of making the cell culture media, and methods of using the cell culture media to improve growth characteristics of cultured cells.
    Type: Grant
    Filed: June 21, 2016
    Date of Patent: April 14, 2020
    Assignee: Ventria Biosciences Inc.
    Inventors: Steven Clyde Pettit, Mary Ann Michelle Fernandez Santos, Ning Huang
  • OspA Fusion Protein for Vaccination against Lyme Disease
    Publication number: 20160213766
    Abstract: Provided herein are monocot seed compositions and methods of making a monocot seed product expressing high levels of recombinant Osp fusion protein. In some embodiments, a rice seed composition is used in the manufacture of a Lyme disease vaccine formulation. In some embodiments, the composition comprising the Osp fusion protein is admixed with a drug or pharmacologically active agent, such as an antibiotic.
    Type: Application
    Filed: September 23, 2014
    Publication date: July 28, 2016
    Applicant: Ventria Bioscience, Inc.
    Inventors: Ning HUANG, Deshui ZHANG, Barbara J.B. JOHNSON, Chris MACMANUS
  • Non-glycosylated transferrin expressed in monocots
    Patent number: 9321828
    Abstract: Disclosed are compositions and methods of making non-glycosylated transferrin protein in transgenic monocot plants.
    Type: Grant
    Filed: May 6, 2011
    Date of Patent: April 26, 2016
    Assignee: Ventria Bioscience Inc.
    Inventors: Deshui Zhang, Ning Huang, Diane Phuong Nguyen, Paula Bryan
  • Monocot seed product comprising a human blood protein
    Patent number: 8686225
    Abstract: The invention is directed to blood proteins produced in monocot seeds and isolated therefrom for use in therapeutic compositions, as well as to methods of making these isolated blood proteins and to therapeutic compositions comprising them.
    Type: Grant
    Filed: April 17, 2012
    Date of Patent: April 1, 2014
    Assignee: Ventria Bioscience Inc.
    Inventors: Ning Huang, Raymond L. Rodriguez, Frank E. Hagie, David M. Stalker